| 2026-08-11 | Press release | Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook |
| 2026-08-11 | Earnings deck | Seer Q2 2026 Earnings Presentation |
| 2026-08-03 | Press release | Seer to Report Second Quarter 2026 Financial Results on August 11, 2026 |
| 2026-08-03 | Press release | Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference |
| 2026-07-30 | Press release | Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad |
| 2026-07-20 | Press release | Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, |
| 2026-07-14 | Press release | Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight |
| 2026-07-08 | Press release | Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nomin |
| 2026-07-02 | Press release | Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. |
| 2026-07-01 | Press release | Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics |
| 2026-06-22 | Press release | Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics f |
| 2026-06-15 | Press release | Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Add |
| 2026-05-29 | Press release | Seer Files ITC Complaint Against Nanomics |
| 2026-05-26 | Press release | Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026 |
| 2026-05-21 | Press release | Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group |
| 2026-05-13 | Press release | Seer Files Patent Infringement Lawsuit Against Nanomics |
| 2026-05-04 | Press release | Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer |
| 2026-04-27 | Press release | Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group |
| 2026-04-13 | Press release | Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group |
| 2026-04-09 | Press release | Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE |
| 2026-03-30 | Press release | Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries |
| 2026-02-26 | Press release | Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets |
| 2026-02-19 | Press release | Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Resear |
| 2026-02-18 | Press release | Seer to Participate in the TD Cowen 46th Annual Health Care Conference |
| 2026-02-05 | Press release | Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 |